Venture Kick is a philanthropic funding program initiated to support Swiss startups by providing early-stage capital and mentorship. It aims to accelerate the development of high-potential business ideas from Swiss universities and increase their attractiveness to investors and industry partners.

The Venture Kick philanthropic initiative provides up to CHF 150,000 in seed funding to Swiss startups and offers a well-structured entrepreneurial path toward building a winning business. Startups pitch to expert juries at three stages to obtain funding and gain direct feedback and access to an international network of 200 successful entrepreneurs and investors. Winners of Venture Kick are eligible for a CHF 850,000 investment from the Kickfund and an InnoBooster grant of an additional CHF 150,000.

Since its launch in 2007, Venture Kick has supported 1,000 Swiss startup projects with CHF 50.3 million. Thanks to financial support, coaching and networking with investors, this initiative has led to the emergence of 783 thriving startups and the creation of 13,305 jobs. Venture Kick counts a portfolio of 675 active high-tech companies and 68 exits. Venture Kick alumni companies have attracted a total of CHF 7.8 billion and represent 64 companies ranked in the TOP 100 Swiss Startups in 2023.

In 2023, Venture Kick paid out 6.3 million Swiss francs to startup projects from Swiss universities to bring science-based innovations to global markets.

The Venture Kick Foundation is supported by Gebert Rüf Stiftung, Ernst Göhner Stiftung, Fondation ALCEA, Hauser-Stiftung, André Hoffmann, Hansjörg Wyss, Martin Haefner, Fondation ProTechno, ESA BIC Switzerland, and Swisscom.

Apply now: https://www.venturekick.ch/apply

modum

Versantis

Bicycle Therapeutics

Poken

Onward

HouseTrip

Fashwell

FGen

STIMIT

Advanon

Amal Therapeutics

Andrew Alliance

BARD1 Life Sciences

Venture Kick

15 years of changing the world - one startup a time: we celebrate all the brave entrepreneurs, the teams, investors, and supporters for the incredible journey together with Venture Kick! Thank you all - you are truly kicking it!!!

Read more about our history, shaping the future: https://lnkd.in/eSNkfeuP

#SwissStartups #VentureKick 

CHF 40,000 for a disruptive blood diagnostic solution, efficient airflow for industries, and reusable radiosondes: AiMorphous Health, Ionic Wind Technologies, and R2HOME advance to the next stage of Venture Kick. Congrats to science entrepreneurs Ming Zou, San P., Daniel Shoukier, Donato Rubinetti, and Yohan Hadji!
https://lnkd.in/gufgpWSE

AiMorphous Health: Disruptive blood diagnostic for prevention of thrombosis and bleeding
https://lnkd.in/ePxjrTcT

Ionic Wind Technologies: Pioneering efficient airflow for cleaner and greener industrial production
https://lnkd.in/e6ca_qd5

R2HOME: Making Radiosondes Reusable
https://lnkd.in/ed7vdrpC

#SwissStartups #VentureKick

Boosting new inventions in B2B communication, medtech, clean energy, and lab research: Hoshī, INCAPTEK, PitchMe, Scanvio Medical, and Visienco enter Venture Kick, receiving CHF 10'000 each. Ayoub Chouak, Jiir Awdir, Olga Fontanellaz, Gleb Sukhorukov, Yury Moshkin, Daniel Fernex, Sébastien Le Fouest, Fabian Laumer, Stefan Tuchschmid, Lucie Jandet and Jonas Goldowsky!
https://lnkd.in/eXdchdxV

Hoshī: AI-powered chat interface for B2B wholesalers
https://lnkd.in/eTnmWY35

INCAPTEK: Next-generation smart drug-eluting coatings for medical devices
https://lnkd.in/eQ2DhnKn

PitchMe: smart wind energy as a service to help farmers, SMEs, and local authorities achieve energetic independence
https://lnkd.in/e7VJp5it

Scanvio Medical: Democratize expert ultrasound
https://lnkd.in/eZEnebPz

Visienco: Bringing automated, gentle organoid sorting to your lab
https://lnkd.in/eW-znkuS

#SwissStartups #VentureKick

CHF 150,000 to redefine regenerative medicine through protein engineering: Orio Therapeutics wins final stage of Venture Kick. Congratulations and best of success to founders and EPFL alumni Ziad Julier and Mikaël Martino!
https://lnkd.in/d3eT4p4N

About: The limited clinical success of many protein-based therapeutics is often due to poor delivery systems. The injected molecule diffuses quickly away from the injection site, which represents a significant challenge, especially in regenerative medicine where local action is crucial for tissue regeneration and repair. Orio Therapeutics addresses the issue by allowing precise control over medication delivery. By modifying therapeutic proteins to incorporate a built-in delivery system, the method ensures they remain at the targeted injection site.

#SwissStartups #VentureKick

CHF 150,000 to simplify the monitoring and analysis of political processes: EPFL spin-off DemoSquare wins final stage of Venture Kick. Congratulations to the team of founders Victor Kristof and Jérémie Rappaz!
https://lnkd.in/eVNwwBKz

About: Few aspects impact businesses more than regulation. However, monitoring and reporting on public affairs is a tedious and time-consuming task for companies. Leveraging proprietary AI technologies, DemoSquare is offered as a SaaS platform to collect, monitor, analyse, and report on legislative and political activities, allowing public affairs managers to save up to 16 hours a week.

#SwissStartups #VentureKick

CH:VENTUREKICK

Venture Kick

Analysis Not Available